Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.870 | 3.870 | 0.000 |
Stocks | 96.130 | 96.130 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.442 | 12.006 |
Price to Book | 2.055 | 1.808 |
Price to Sales | 0.954 | 1.139 |
Price to Cash Flow | 8.955 | 7.133 |
Dividend Yield | 3.568 | 4.527 |
5 Years Earnings Growth | 16.288 | 8.923 |
Name | Net % | Category Average |
---|---|---|
Technology | 20.180 | 5.663 |
Industrials | 18.350 | 14.166 |
Consumer Cyclical | 16.820 | 9.315 |
Healthcare | 12.700 | 13.234 |
Basic Materials | 12.050 | 6.797 |
Consumer Defensive | 5.170 | 11.512 |
Financial Services | 4.090 | 22.123 |
Energy | 4.000 | 5.747 |
Communication Services | 3.420 | 5.997 |
Utilities | 3.220 | 7.806 |
Number of long holdings: 38
Number of short holdings: 2
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Siegfried Holding Ltd | CH0014284498 | 4.67 | 1,114.00 | +0.91% | |
Gerresheimer AG | DE000A0LD6E6 | 4.19 | 71.95 | +2.10% | |
Dunelm | GB00B1CKQ739 | 3.99 | 1,154.00 | +1.76% | |
IG Group | GB00B06QFB75 | 3.93 | 936.00 | -1.21% | |
DCC | IE0002424939 | 3.84 | 5,615.0 | +0.45% | |
Glanbia PLC | IE0000669501 | 3.81 | 14.75 | +1.37% | |
Pets at Home Group | GB00BJ62K685 | 3.79 | 280.00 | +0.65% | |
D’Ieteren | BE0974259880 | 3.69 | 204.80 | +4.07% | |
Vicat | FR0000031775 | 3.62 | 36.85 | +0.27% | |
Loomis B | SE0014504817 | 3.61 | 328.00 | 0.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Lupus alpha Panopean Smaller Comp | 172.66M | 2.89 | -6.51 | 7.29 | ||
Lupus alpha Dividend Champions R | 140.26M | -3.02 | -8.13 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review